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lacking specific attachment sites required for anchorage-dependent cells. In this work, we modify purifiedGG polymer with a short peptide containing the arginine-glycine-aspartic acid (RGD) sequence that is
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Rheological studies revealed that the peptide coupling did not prevent gelation behaviour. C2C12 cells
showed improved attachment on the surface of and encapsulated within RGD-GG hydrogels,
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Peptide modification of purified gellan gum
C. J. Ferris,† a,b L. R. Stevens,† a,b K. J. Gilmore,a E. Mume,c I. Greguric,c D. M. Kirchmajer,a,b G. G. Wallacea,*
and M. in het Panhuisa,b *
Gellan gum (GG) is an anionic polysaccharide with potential as a biopolymer for additive manufacturing (3D-bioprinting) and
tissue engineering. Previous studies have shown GG to be highly cytocompatible, but lacking specific attachment sites required
for anchorage-dependent cells. In this work, we modify purified-GG polymer with a short peptide containing the arginineglycine-aspartic acid (RGD) sequence that is known to enhance integrin-mediated cell attachment. Radiolabelling of the peptide
was used in optimisation of the conjugation procedure to achieve an overall efficiency of 40%. The purification of divalent
cations from commercial GG samples was found to be critical for successful conjugation. Rheological studies revealed that the
peptide coupling did not prevent gelation behaviour. C2C12 cells showed improved attachment on the surface of and
encapsulated within RGD-GG hydrogels, differentiating to multinucleated myofibers after 5-7 days. PC12 cells showed
minimal interactions with both GG and RGD-GG, with formation of cell clusters and impedance of terminal differentiation and
neurite extension.

	
  

Introduction
The use of biopolymers that mimic the extracellular matrix to
form scaffolds for cell culture is a well-established technique
that has been employed over several decades. The more recent
developments in additive manufacturing (or biofabrication),
particularly 3D-bioprinting, have paved the way for the
formation of complex tissue structures by layering cells and
biomaterials in a spatially controlled manner1. In many cases
however, biomaterials that are optimised for processing do not
support cellular interactions and vice versa2. Most cell types are
anchorage-dependent, and must anchor to a suitable substrate in
order to facilitate normal behaviour3, 4. The creation of new
materials that combine the support of correct cell behaviour
with versatile processability will be key to realising the
potential of biofabrication.
Gellan gum (GG) is an anionic polysaccharide comprised of
a repeating tetramer, with one carboxylate functionality per
repeat unit 5. The structural and functional similarities between
GG and the widely used alginate have helped identify it as a
prime candidate for tissue engineering applications. The current
uses and future potential of GG has been the focus of reviews in
20005 and 20136, 7 and several studies have demonstrated the
processability and versatility of GG7-9. In particular, GG has
been employed as a material for bio-printing of cells and cellscaffolding structures 10-12. The biocompatibility of GG has also
been probed. Rat bone marrow cells8, rabbit articular cartilage
cells13 and human chondrocytes9 have all survived in GG,
however these cell types are attachment-independent. Studies
utilising anchorage-dependent cell lines have shown that GG is
not an instructive cell encapsulation matrix. For example,
fibroblasts14 and oligodendrocytes15 photo-encapsulated in
methacrylated GG hydrogels maintained a non-responsive

	
  

phenotype and showed reduced viability after several days in
culture. Similar results have been obtained for analogous
polysaccharide gel systems, with cardiomyocytes encapsulated
in chitosan hydrogels16 and endothelial cells encapsulated in
alginate17 showing a lack of cell adhesion. These results make it
apparent that modification of GG hydrogels is required to
support the adhesion, growth and normal function of
anchorage-dependent cells.
The blending of complete proteins with polysaccharides is a
popular approach for addressing this issue, as they contain the
biofunctionality native to the extracellular matrix (ECM).
Polysaccharides including alginate18, 19, chitosan20 and
hyaluronic acid21 have all been blended with collagen and/or
laminin to create composite hydrogels that encourage the
attachment and growth of encapsulated cells. Alternatively,
polysaccharides may be directly functionalised to produce
materials that combine both processability and cellular
attachment sites. The tri-peptide sequence arginine-glycineaspartic acid (RGD) has been identified as the cell attachment
site in many ECM proteins and is pivotal to integrin-mediated
cell binding22, 23. This peptide, and other similar sequences,
have been widely utilised to modify polymer biofunctionality24.
One of the most common applications of this approach is the
conjugation of RGD peptides to alginate25. Other research in
this area involves modification of alginate with the peptide
G4RGDY, including a 6-month implantation study with a rat
model, which showed good vascularisation and tissue
integration in vivo26. The potential of RGD-alginates for
injectable systems by delivering endothelial cells encapsulated
in RGD-modified alginate in vitro has also been reported17,
while the potential of peptide-modified alginates for spinal cord
repair has been demonstrated27. Human fibroblasts28 and
adipose derived stem cells29 have also been incorporated into

	
  
peptide-modified alginate gels. More recently, furan
functionalisation of GG, followed by a Diels-Alder reaction
with a synthetic variant of the GRDGS peptide was used to
direct neural and mesenchymal stem cell differentiation with
encouraging results30, 31.
In this paper, we covalently linked unmodified peptides to
GG, and monitored the reaction efficiency by tyrosine
radiolabelling. The impact of RGD modification on GG’s
physical properties and cell interaction are presented.

Experimental
Gellan gum purification
All materials were obtained from Sigma, unless specifically
stated otherwise. Commercial samples of low-acyl GG obtained
from CP Kelco (traded as Gelzan™ CM) were purified to
remove divalent cation using an established method32-34. A 1%
(w/v) GG solution was formed by dissolving Gelzan™ CM (0.5
g) in 50 mL of hot Milli-Q water (60 °C, resistivity 18.2 MΩ
cm). 1.25 g of Dowex 50W-X8 cation exchange resin (Fluka,
H+ form, 50-100 mesh), pre-rinsed in 1 M HCl and Milli-Q
water, was then added and the hot mixture was stirred for 30
min to convert GG to the free acid form (gellanoic acid). The
resin was allowed to settle and the supernatant decanted into a
pre-heated beaker through a coarse filter. The resin was rinsed
twice with small volumes of 60 °C water and added to the
supernatant. To this solution (kept at ~ 60 °C), 4 M NaOH was
added dropwise until the pH stabilised at ~ 7.5 to convert the
gellanoic acid to the sodium salt (sodium gellanate, NaGG).
After stirring for an additional 5 min, 100 mL of 2-propanol
was added with continued stirring to precipitate a white fibrous
product. This product was vacuum filtered, washed with 2propanol and dried under vacuum overnight before being
chopped into a fine powder and stored under cool, dry
conditions until required.

was taken as
measurements.

twice

the

standard

deviation

of

blank

RGD conjugation reaction
Peptides were coupled to NaGG using a wide variety of
conditions. Under optimal conditions, 100 mg of NaGG was
dissolved in a premade 50 mM solution of 2-(Nmorpholino)ethanesulfonic acid (MES) buffer (pH 6.5) by
stirring at ~60 °C to yield 10 mL of a 1 % (w/v) NaGG
solution. In a separate vial, 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide (EDC, Sigma) was added under N2 gas and
dissolved in MES buffer to yield a solution of 0.3 M EDC, 50
µL of which was immediately transferred to the NaGG solution.
50 µL of a 0.15 M solution of N-hydroxysulfosuccinimide
(sulfo-NHS) in MES buffer was added to the reaction vessel.
The solution was then vortexed and allowed to activate at 37 °C
for 15 mins (Figure 1: Reactions 1,2). After activation,
G4RGDSY and G4RGESY peptide (Auspep) solutions were
added in sufficient quantity to bind to 1 mol% of total
carboxylate groups and the mixtures (RGD-GG and RGE-GG,
respectively) were retained overnight at 37 °C (Figure 1:
reaction 3). A third mixture (GG/RGD) was prepared using a
NaGG solution without addition of EDC, but coupled with 1
mol% G4RGDSY.
After reaction, solutions were purified by dialysis against
Milli-Q water over 5 days using Slide-a-Lyzer mini dialysis
devices (0.1 mL, MWCO 10 kDa, ThermoScientific). The
dialysed product was lyophilised for 2 days and then stored
under cool (4 °C), dry (sealed in flask) conditions prior to use.

Atomic absorption spectroscopy
The concentration of Na, Ca, K and Mg in GG and NaGG was
determined using flame atomic absorption spectroscopy (AAS)
burning acetylene/air. Samples were analysed using a Spectra
AA 220FS (Varian) spectrometer equipped with sodium (589.6
nm), potassium (769.9 nm), calcium (422.7 nm) and
magnesium (285.2 nm) hollow cathode lamp sources. Samples
were prepared by digesting 1 g of dry material in 5 mL of hot
concentrated sulphuric acid (Ajax Finechem), followed by
dropwise addition of hydrogen peroxide (30% (v/v), Ajax
Finechem) until the solution became transparent. The solution
was allowed to cool prior to the addition of 16 mL of 12.6
mg/mL caesium chloride ionisation suppressant. The solution
was then made up to 100 mL with the addition of Milli-Q H2O
and mixed thoroughly prior to measurement. Concentrations
were blank-corrected and interpolated from calibration curves
prepared using a certified multi-element standard solution
(Inorganic Ventures). The limit of detection for each element

	
  

Figure 1: Reaction scheme for the peptide modification of purified GG,
performed in three-steps: (1) EDC activation of the carboxylate on the
GG backbone forming an unstable intermediate; (2) sulfo-NHS
stabilisation of the reactive intermediate; and (3) peptide coupling to the
GG backbone and regeneration of sulfo-NHS.

	
  

Radiolabelling to determine conjugation efficiency
For quantitative analysis of peptide binding to purified GG, the
peptide G4RGDSY was radiolabelled through radio-iodination
of the tyrosine residue using the well-established chloramine-T
method35. Iodine-125 carrier free radionuclide was purchased
from Perkin-Elmer (Na125I, t1/2 = 59.4 days, NEZ033H010MC).
50 µL of a 1 mg/mL solution of G4RGDSY in Milli-Q water
was diluted with 180 µL of 0.1 M sodium phosphate buffer (pH
6.0). A 50 µL aliquot of Na125I (diluted 1:50 in 1 mM NaOH)
was added, followed by 10 µL of 1 mg/mL chloramine-T in
buffer. After 5 min, the reaction was quenched by the addition
of 10 µL of sodium metabisulfite (Merck) at 2.5 mg/mL in
buffer. The reaction mixture (300 µL total) was loaded onto an
Oasis HLB SPE cartridge (Waters) that had been preequilibrated by eluting 5 mL methanol, 5 mL water and 10 mL
0.1% trifluoroacetic acid (TFA) in water (solvent A). The
cartridge was then washed with 20 mL of solvent A to remove
unbound iodine-125. Two fractions were eluted, the first with 4
mL of a 1:1 mixture of solvent A with 0.1% TFA in acetonitrile
(solvent B), and the second with 4 mL of solvent B. The two
fractions were pooled, dried in a rotary evaporator and redissolved in Milli-Q water (350 µL).
The concentration and purity of the radiolabelled peptide
was confirmed by radio-HPLC analysis using a Shimadzu
HPLC-DAD system equipped with an In/Us Systems gamma
ram detector and an Eclipse XDB-C18 column (Agilent,
250x4.6 mm) with 5 µm particle size. Compounds were eluted
using 30% (v/v) acetonitrile and water at a flow rate of 1
mL/min, isocratic, over 15 min. Peptide concentration was
calculated using a calibration curve constructed from HPLC
chromatograms
of
G4RGDSY
solutions
of
known
concentration, plotting integrated peak area (λ = 254 nm) as a
function of peptide concentration
Radiolabelled peptides were then coupled to NaGG as
described above. Reaction products were separated using Zeba
spin desalting columns (0.5 mL, MWCO 40 kDa, 50 °C
ThermoScientific) to remove unconjugated peptide and other
small reaction species from the peptide-conjugated NaGG. The
radioactivity in all components of the system (i.e. sample,
filtrates, eluates, dialysates, separation devices) was measured
using a Perkin Elmer 2480 WIZARD2 gamma counter and
converted to specific activity by calibration against known
samples of 125I-G4RGDSY. Conjugation efficiencies reported
here are the ratios of specific activity in NaGG bound peptides,
to the total activity recorded across all components.
Rheology
The rheological characteristics of GG, NaGG and RGD-GG
hydrogels were investigated using an Anton Paar Physica MCR
301 rheometer equipped with a temperature controlled mantle
and base plate. 1% (w/v) solutions of commercial GG, purified
NaGG and modified RDG-GG were formed in Milli-Q water

	
  

by stirring overnight at 50 °C. Viscosity was measured between
0.1 and 100 1/s shear rate at 37 °C.
The 1% (w/v) polymer solutions and two solutions of CaCl2
with concentrations of 1% (w/v) and 0.9% (w/v), respectively
were placed in a water bath at 80 °C. Receiving wells were
formed from pre-cut cylinders of polyvinyl chloride (PVC) with
internal diameter of 18 mm and height of 5 mm, which were
placed in Petri dishes and sealed around the base with silicon
sealant. 4.5 mL of each hot polymer solution was then mixed
with 500 µL of CaCl2 solution to yield final Ca2+ and polymer
concentrations of 9 mM and 0.9% (w/v) respectively. NaGG
and RGD-GG were mixed with 1% (w/v) CaCl2, whilst
commercial GG received 0.9% (w/v) CaCl2 to adjust for the
Ca2+ content already present in the material as determined by
AAS (Table 1). Immediately after mixing, these solutions were
pipetted into the PVC moulds and allowed to gel at 4 °C for 1
h. Once formed, hydrogels were transferred to the rheometer
and equilibrated to 37 °C. Each hydrogel was slightly
compressed using a 15 mm stainless steel parallel plate and
tested under oscillating shear, with the strain amplitude rising
from 0.01% to 100% shear strain at a constant angular
frequency of 5 Hz.
Cell response
The phenotypic cell response to RGD-GG was assessed with
the anchorage-dependent murine skeletal muscle C2C12 cell
line and the neuronal rat pheochromocytoma PC12 cell line,
both obtained from the American Type Culture Collection
(ATCC). For surface seeding experiments, 0.15% (w/v)
solutions of GG, GG/RGD, RGE-GG and RGD-GG were
pipetted into 96-well plates and gelled by the slow addition of
concentrated Dulbecco's Modified Eagle's Medium (DMEM,
Invitrogen) down the wall of the well. Hydrogels were then
formed at 37 °C and equilibrated over 1 h using two changes of
cell proliferation media (CPM), specifically DMEM
(Invitrogen) supplemented with 10% (v/v) foetal bovine serum
(FBS, Invitrogen) for C2C12 cells, and DMEM with 5% (v/v)
FBS and 10% (v/v) horse serum for PC12 cells. Cells were
seeded at 5000 cells/well and incubated at 37 °C and 5% (v/v)
CO2 with media changes every 2 days. Cell morphology was
assessed daily using bright field microscopy, and cell viability
was assessed using calcein AM (Molecular Probes, Life
Technologies) and propidium iodide (PI) staining and
fluorescence imaging for up to 6 days in culture. Differentiation
was induced by switching to low serum media, i.e. DMEM with
2% (v/v) horse serum for C2C12 cells and DMEM with 1%
(v/v) horse serum and 50 ng/mL nerve growth factor (NGF,
Life Technologies) for PC12 cells. Differentiating cells were
cultured for up to 6 days with media changes every 2 days.
Immunostaining was used to characterise the phenotype of
differentiated C2C12 and PC12 cells. For C2C12 cells, staining
targeted desmin, a sarcomeric intermediate filament protein
expressed in skeletal muscle. For PC12 cells, staining targeted
β-III tubulin, a globular microtubule protein expressed
exclusively in neurons. In each case, cell nuclei were counter-

	
  
stained using 4’,6-diamidino-2-phenylindole (DAPI, 1 µg/mL),
which binds strongly to DNA. Differentiated cells were fixed
with 3.7% paraformaldehyde (PF, Fluka) in phosphate buffered
saline (PBS) for 10 minutes at room temperature (21 °C, RT)
and stored in PBS containing calcium and magnesium (DPBS)
at 4° C prior to staining.
For staining of C2C12 cultures, cells were permeabilised
with 50:50 methanol:acetone on ice for 5 minutes and washed
with DPBS before blocking in 10% donkey serum (DS,
Chemicon) with 0.05% Tween-20 (Sigma) for 1 hr at 21°C.
Mouse monoclonal anti-desmin primary antibody (Novocastra)
was diluted 1:100 in blocking solution and incubated at 4°C
overnight. After two 10 min washes in DPBS, cells were
incubated for 1 hr at 25˚C in the dark with the secondary
antibody Alexa-546 donkey anti-mouse (Invitrogen) diluted
1:1000 in blocking solution. After two 10 min washes in DPBS,
DAPI (Molecular Probes) was added at 1:1000 in DPBS for 5
min at 21 °C, before replacing with fresh DPBS and imaging
using a Zeiss Axiovert inverted fluorescence microscope. For
staining of PC12 cells, the same protocol was followed,
however the primary antibody (anti-b-tubulin, Covance) was
diluted 1:1000. Incubation times for all immunostaining
reagants were doubled when cells were encapsulated in
hydrogels rather than surface seeded.
For cell encapsulation studies sucrose was used to protect
cells from any potential osmotic injury resulting from exposure
to the hypotonic GG solution before addition of culture media.
A GG solution at twice the desired final concentration was
combined with an equal volume of a 20% (w/v) sucrose
solution. This working solution was then used to resuspend
cells that had previously been washed and suspended in 10%
(w/v) sucrose at 5 x 105 – 2 x 106 cells/mL and pipetted into 96well plates. CPM containing 5 mM CaCl2 was then slowly
added down the side of each well to crosslink the GG-cell
suspensions. Media was changed twice over a period of 1 hr
using CPM without additional CaCl2, and cells were maintained
and monitored over time in culture with media changes every
48 h.
MTS assays (Promega Corp.) were conducted according to
the manufacturer’s protocol on encapsulated C2C12 and PC12
cell cultures proliferating for periods up to 72 hr in NaGG and
RGD-GG hydrogels at a polymer concentration of 0.15% (w/v).

groups in GG, reducing their availability for reaction with
EDC, and therefore the peptide.
To negate this impact, we purified our commercial GG
samples (following a published procedure32-34) to remove
divalent cations and yield monovalent cation salts. The product,
sodium gellanate (NaGG), was a white fibrous product at ~
60% yield by weight (Figure 2). The concentration of Na+ in
NaGG was equivalent to ~ 72.5 mol% of carboxyl groups.
Hence, substantial percentages of the carboxylate sites were
available for peptide coupling using the purified product.
Additionally, In 2005, Ogawa et al. reported NaGG shifts from
a random coil to a helixed state between 30-35˚C 36. This
transition is a key process in GG gellation and implies that
NaGG will resist gellation at physiological temperature (37˚C)
until divalent cations are added. The reduced prevelance of
premature gellation allowed for thee dissolution of higher
concentrations of GG at physiological temperatures, providing
an additional avenue for improving the reaction efficiency in
EDC-mediated peptide conjugation.

Results and discussion

Peptide conjugation to purified GG

Gellan gum purification
The concentrations of major monovalent (Na+, K+) and divalent
(Ca2+, Mg2+) cations in as-received (commercial) GG and
purified NaGG were measured by atomic absorption
spectroscopy (Table 1). Commercial samples of GG are
predominantly in the potassium salt form, with lesser amounts
of Na+, Ca2+ and Mg2+ as the other major cations. The measured
concentrations of divalent cations in commercial gellan gum
were sufficient to neutralize around one-third of the carboxylate

	
  

Table 1: Concentration of major cations present in as-received
(commercial) gellan gum (GG) and purified sodium gellanate (NaGG),
measured by atomic absorption spectroscopy.

Element
(% w/w)
GG
NaGG

Na+

K+

Ca2+

Mg2+

0.6 ± 0.1
2.5 ± 0.1

4.5 ± 0.2
1.0 ± 0.1

1.2 ± 0.1
< 0.06

0.11 ± 0.01
< 0.03

Figure 2: Gellan gum (GG) through each stage of processing. From left to
right, as-received (commercial) GG powder, lyophilised NaGG, lyophilised
RGD-GG and a 0.9% (w/v) RGD-GG hydrogel.

Conjugation reactions with NaGG were performed under a
range of conditions including variations to peptide, NaGG,
EDC and sulfo-NHS concentrations, temperature, and reaction
buffer (Table 2, Figure 3). Conjugation of 0.1% (w/v) NaGG
solutions yielded an efficiency (~ 19%) which was significantly
higher than those obtained using commercial GG (<5%, see the
Electronic Supporting Information) under the same conditions.
This clearly indicates that the removal of divalent cation
(present in commercial GG) significantly enhanced the
conjugation efficiency without any additional optimisation of
the reaction. The purification process also afforded better

	
  
control of the gellation process of GG, and enabled conjugation
reactions using more concentrated 0.5% (w/v) and 1.0% (w/v)
NaGG solutions, yielding efficiencies of around 35%.
Based on the data (Table 2, Figure 3) obtained through
radiolabelling, selection of buffer, pH and adequate
concentrations of EDC and GG appear to be the primary
determinants of conjugation efficiency. MES buffer at pH 6.5
was found to significantly out-perform the other tested systems,
however the same buffer at pH 5 yielded no significant peptide
conjugation. These results suggest that a pH of 6.5 achieved a
balance between the reactivity of the EDC, the terminal amine
of the peptide and the carboxyl group on the polymer, a finding
similar to results obtained for alginate.25.
A pH of 6.5 strikes a balance between EDC’s peak
reactivity at pH ~4.5, and that of the terminal amine, which is
strongly activated at pH 8-924. The GG pKa value of 3.06
implies that a pH of 6.5 promotes dissociation in over 99.9% of
available carboxylate residues37. However, despite the similar
pH value (6.7) the sodium acetate buffer impeded RGD peptide
coupling, possibly due to de-activation of EDC by nucleophilic
attack from acetate ions38, underscoring the importance of
appropriate buffer selection.

Table 2: Reaction efficiencies for the EDC-mediated conjugation of
G4RGDSY to NaGG under varying reaction conditions. Reaction
efficiencies were determined by gamma counting of conjugated and
radio-labelled G4RGDSY after separation of unbound peptide by spin
desalting.

NaGG
(%
w/v)

EDC

G4RGDSY

Temp

(%COOH)

(%COOH )

(˚C)

Buffer

(% ±1 STD)
MES

1

20

2

37

1

20

0.2

37

1

20

0.02

37

1

10

2

37

1

5

2

37

Efficiency

pH

6.5

MES pH
6.5

MES pH
6.5

MES pH
6.5

MES pH
6.5

1

20

2

21

1

20

2

60

1

0

2

37

0.5

20

2

37

0.1

20

2

37

1

20

2

37

1

20

2

37

1

20

2

37

1

20

2

37

37.0 ± 1.0
37.8 ± 3.0
30.9 ± 3.1
33.3 ± 2.8
24.4 ± 3.1
MES pH 6.5
35.2
± 0.3
MES pH 6.5
26.9
± 2.3
pH 6.5
MES
9.7 ±
0.6
MES pH 6.5
35.3
± 0.4
MES pH 6.5
18.7
± 0.7
9.92
MES pH 5.0
± 0.8
Na3PO4 pH
15.1
8.0
± 0.3
13.7
NaC2H3O2
pH 6.7
± 1.1
Milli-Q
11.8
H2 O
± 0.8

Figure 3: Peptide (G4RGDSY) conjugation efficiencies as determined after
HPLC by gamma counting of radio-labelled iodine on the terminal tyrosine
of the G4RGDSY peptide. Efficiencies were compared in terms of separation
method (A), NaGG concentration (B), EDC concentration (C), peptide
concentration (D), reaction temperature (E) and buffer selection (F). Blue
shaded data indicate the conditions that were carried across to the other
reactions shown, white bars indicate the additional tested conditions. Red
bars in (A) represent control reactions with no added EDC. Error bars
represent 1 standard deviation of the mean.

The EDC concentration was varied from 0-20 mol% of
available carboxylate groups, with reaction efficiencies rising
four fold over that range. This result is similar to that
previously observed for alginate25, i.e. peak efficiency at an
EDC concentration of 10% of available carboxylate groups.
EDC concentrations above 20% were not employed to
minimise a previously reported side reaction in which the active
ester undergoes internal rearrangement and incorporates into

	
  

	
  
the product25, 39. It is suggested that in the absence of EDC, the
apparent conjugation efficiency of 10% can be attributed to the
presence of unbound RGD peptide (remaining after a single
spin-desalting step). Thorough purification by five-day dialysis
was observed to better separate unbound peptide (Figure 3A).
Ambient (21 ˚C) and physiological (37 ˚C) temperatures
were found to promote conjugation equally well (Figure 3E).
However elevated temperatures (~60 ˚C) were found to reduce
conjugation efficiency. It is likely that this is related to a tradeoff between reaction kinetics of EDC coupling and the
availability of carboxyl groups for activation. The input
concentration of G4RGDSY peptide (when varied over 3 orders
of magnitude) was not observed to significantly alter the overall
conjugation efficiency (Figure 3D).
These results suggest that RGD-peptide density could be
tailored to suit a wide variety of extracellular environments.
The density of RGD peptides presented to cells has been shown
to affect a range of cellular responses including attachment,
spreading, proliferation and differentiation24, 40-42.
The highest efficiency for conjugation of G4RGDSY to
NaGG achieved in this work (~ 40%) was lower than that
observed by for the conjugation of GRGDY to alginate (> 80%)
25
. The lower efficiency could be due to the use of a longer
peptide sequence. This is supported by a subsequent report
demonstrating that a longer peptide G4RGDY conjugated to
alginate resulted in a decrease in efficiency to 55%42.
For our work, we chose to use an RGD-containing peptide
with a poly-glycine tail due to evidence from several studies
indicating the need for a spacer that separates the RGD
sequence from the material to which it is conjugated, enhancing
its availability to cellular integrins24. The required length of this
spacer, or the need for one at all, is largely dependent upon the
structure of the host material. We were therefore guided by
work characterising the effect of glycine tail length on the
response of human fibroblast cells to RGD-modified alginate
hydrogels28. In this report, it was shown that a minimum spacer
length of four glycine units was required to facilitate the
development of focal adhesions, cell proliferation and a
reduction in cell stress markers. The apparent trade-off between
reaction efficiency, optimal with short peptides, and cellular
response, favouring longer peptides, is an observation that
warrants investigation with respect to all RGD-modified
polymers.
Impact of RGD-modification on the rheological behaviour
of GG
One of the key benefits of GG as a biomaterial is its mechanical
and rheological behaviour. Specifically, GG forms selfsupporting hydrogels under physiologically relevant conditions,
but flows freely when no divalent cations are present 43. This
behaviour is mediated by inter-chain helix formation, which is
stabilised by the ionic bridging of neighbouring carboxylate
residues by cations, particularly Ca2+ 44. Modification of GG,
particularly when involving the carboxylate groups, has the
potential to disrupt this behaviour. Rheological testing was

	
  

performed to quantify the impact of peptide modification on the
physical properties of GG. The flow curves of the solutions of
as-received GG and its derivatives (prior to crosslinking)
showed that as-received GG exhibited higher apparent viscosity
values compared with purified NaGG and RGD-GG (Figure S1,
the Electronic Supporting Information, ESI).
Oscillating shear dynamic mechanical analysis was
performed on hydrogels of 0.9% (w/v) as-received GG with 9
µM CaCl2 (Figure 4). Storage modulus (G’) and loss modulus
(G”) are measures of the elastic and viscous behaviours of nonNewtonian materials, respectively. All tested hydrogels
exhibited linear viscoelastic (LVE) regions in which G’ and G”
were invariant with strain. The dominance of G’ over G” in this
region is indicative of fully formed, pseudo-solid hydrogels.
The significant reduction in G’ and G” values for RGD-GG
compared to NaGG indicates a generalised weakening of interchain interactions has resulted from the peptide modification
reaction. The magnitude of this effect is notable given that only
~1 mol% of available carboxylate residues were modified with
G4RGDSY, yet the reduction in G’ and G” was between 1-2
orders of magnitude. This suggests that the peptide alters GG
rheological characteristics in a manner that cannot be singularly
explained by a reduced availability of carboxylate groups. We
propose that the bulky peptide hinders the formation of interchain helicies between adjacent GG chains, which typically
precedes ionic cross-linking43. Importantly, the rheological
characterisation has demonstrated that peptide conjugation does
not prevent gellan gum’s gelation behaviour that is so critical to
many applications in tissue engineering and additive
manufacturing (although weaker gels are formed).
Table 3: Linear viscoelastic (LVE) region in terms of storage (G’) and
loss (G”) moduli of hydrogels formed from commercial (GG), purifed
(NaGG) and RGD-modified (RGD-GG) gellan gum. The end point of
the LVE reported here is taken to be the onset of a sustained rise in the
loss modulus, typically around 0.5% strain.

	
  

GG

NaGG

RGD-GG

LVE G’
(kPa)

105 ± 35.3

85.9 ± 6.0

5.64 ± 0.37

LVE G”
(kPa)

10.0 ± 0.32

4.5 ± 1.3

0.37 ± 0.15

End LVE
(Strain %)

0.21 ± 0.06

0.35 ± 0.12

0.82 ± 0.51

	
  

Figure 4: Oscillatory shear rheometry, sweeping shear strains from 0.01100% at 37˚C. Tests were performed on 10 mm x 17 mm hydrogel cylinders
comprising 9 mM CaCl2 and 0.9% (w/v) of A: commercial GG, B: purified
NaGG and C: peptide modified RGD-GG.

Cell response to peptide-modified gellan gum
We investigated the response of two cell lines to RGD-GG, the
murine skeletal muscle C2C12 cell line which is anchoragedependent, and the rat pheochromocytoma PC12 cell line,
which exists as both adherent and suspended populations in
standard tissue culture on polystyrene. After initial optimisation
of the concentration of NaGG for cell surface seeding, these
cells were seeded both on the surface of, and encapsulated
within, 0.15% (w/v) NaGG and 0.15% (w/v) RGD-GG
hydrogels with the peptide coupled at 0.1 mol% and 1 mol% of
available carboxyl groups, denoted as RGD-GG(0.1%) and
RGD-GG(1.0%). The RGD-peptide concentration in the latter
hydrogels is approximately 9 µmol/L, with an effective surface
availability of approximately 4.5 fmol/cm2, calculated using the
established methods42,24.
In order to rule out that any changes to cell response could
be due to changes in the physical characteristics of the hydrogel
rather than as a result of specific integrin-mediated interactions
with the RGD peptide, control samples of NaGG were
conjugated with the peptide G4RGESY at 1 mol%, denoted
RGE-GG(1%). The RGE sequence differs chemically from the
RGD sequence by only one –CH2 group, however this minor

	
  

change has a significant effect on its integrin affinity, which is
several orders of magnitude lower than for RGD45. An
additional hydrogel control sample was prepared using a
mixture of NaGG (without added EDC) and 1 mol%
G4RGDSY, denoted GG/RGD. As the RGD is not conjugated,
but non-specifically bound to GG, there is a lower amount of
peptide remaining due to the dialysis procedure (Figure 3A).
Figure 5 shows cells seeded on the surface of 0.15% (w/v)
RGD-GG hydrogels and 0.15% (w/v) NaGG controls after 24 h
in culture. Cells on unmodified NaGG surfaces formed large
aggregates typical of poor adhesion to the substrates. Cells
formed similar aggregates on RGE-GG(1%) indicating that
conjugation of this non-integrin-targeting sequence did not
modify cell attachment to the surface. On GG/RGD, the
hydrogel containing non-specifically bound peptide, cell
aggregates were smaller but there was little evidence of cell
spreading.
On the surface of RGD-GG(1%) hydrogels however,
C2C12 cells were observed to rapidly attach, and few large cell
clusters were observed. After 24 h of culture, C2C12 cells
exhibited a typically flattened and elongated morphology,
indicating the development of strong cell adhesions and
implicating specific integrin-mediated interaction. C2C12 cell
attachment was dependent on RGD density, as cells seeded on
hydrogels with a lower concentration of RGD peptide, RGDGG(0.1%), adopted a rounded morphology or formed small
aggregates with few flattened and elongated cells (Figure 5E).
PC12 cells retained rounded morphologies typical of this cell
line under proliferation conditions (data not shown).
C2C12 cells encapsulated in peptide-modified and control
hydrogels (Figure 5F-J) showed a similar range of responses to
those seeded on corresponding hydrogel surfaces. Cells in
NaGG maintained a rounded morphology reflective of a lack of
adhesive interactions (Figure 5F). A similar response was
observed for cells encapsulated in RGE-GG(1%) (Figure 5G)
and GG/RGD (Figure 5H) hydrogels, in agreement with
surface-seeded results. RGD-GG(1%) hydrogels, however,
supported the attachment and proliferation of encapsulated
C2C12 cells (Figure 5I). This effect was observed to a lesser
extent for the lower peptide density hydrogel formed using
RGD-GG(0.1%) (Figure 5J). PC12 cells, in contrast, showed
minimal change in morphology resulting from the presence of
RGD, with the majority of cells remaining in clusters
independent of the presence of RGD-peptide (Figure S2, ESI).

	
  
peptide afforded a better growth environment to both of the cell
lines over a 72 h culture period.
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Figure 6: MTS assays for encapsulated PC12 (A) and C2C12 (B) cells
under proliferative conditions over a 72 h period. Grey and black bars
indicate 0.15% (w/v) hydrogels formed using RGD-GG(1.0%) and
NaGG, respectively. The increased metabolic activity in cells
encapsulated in RGD-GG was statistically significant at the **99% or
*97% confidence level (Student’s T test).

Figure 5: C2C12 cells seeded on the surface of (A-E) and encapsulated
within (F-J) 0.15% (w/v) hydrogels after 24 h under proliferation
conditions. Hydrogels were formed from unmodified NaGG (A, F),
RGE-GG(1%) (B, G), GG/RGD (C,H), RGD-GG(1%) (D, I), RGDGG(0.1%) (E, J). Scale bars represent 50 µm.

Both C2C12 and PC12 cells were observed to proliferate when
surface seeded or encapsulated within the RGD-GG(1.0%) gels.
MTS assays were used to quantify changes in the cellular
metabolic activity of encapsulated cells, which can be related to
changes in cell number or activity within the cell population.
MTS assays applied to GG encapsulated PC12 and C2C12 cells
showed that the overall metabolic activity was greater for cells
encapsulated in 0.15% (w/v) RGD-GG(1.0%) hydrogels than in
the equivalent NaGG hydrogels.
For PC12 cells there was a consistent increase in metabolic
activity over a 72 h period that reflected the observed
proliferation of encapsulated cells (Figure 6A). For C2C12
cells, the increase in metabolic activity was consistently
delayed (Figure 6B). However, at alltime points the cellular
metabolic activity in RGD-GG(1.0%) gels was higher than that
in the corresponding NaGG gels, indicating that the RGD

	
  

Both encapsulated and surface-seeded cells were induced to
differentiate by exposure to low serum conditions. After only
12 h, C2C12 cells on the surface of RGD-GG had formed into
large multi-cellular fibres and aggregates, and this contraction
continued with further culture. C2C12 cells cultured on
polystyrene take up to 6 days to differentiate, however early
differentiation has previously been observed for C2C12 cells on
the surface of RGD-alginate hydrogels25. This was attributed to
the compliant nature of the hydrogel substrate, and could be the
reason for the rapid cell response observed in the current work.
After 5 days incubation under differentiation conditions,
fixed and immunostained samples showed formation of
multinucleated myofibres, typical of differentiated skeletal
muscle (Figure 7A). Encapsulated C2C12 cells were also found
to differentiate into multinucleated skeletal muscle fibres within
RGD-GG(1.0%) hydrogels (Figure 7B-C), in contrast to the cell
behaviour observed within gels prepared without the peptide
(Figure 7D). The extent of multinuclear fibre formation was
found to be dependant on the encapsulated cell density, i.e. at
higher cells density (2x106 cells/mL) a higher percentage of
cells were incorporated into fibres than at lower density
(0.5x106 cells/mL). This behaviour corresponds to the observed
role of skeletal muscle cell density culture.

	
  

Conclusions

Figure 7: (A) Surface seeded and (B, C) encapsulated C2C12 cells after 5
days of culture in 0.15% (w/v) RGD-GG(1.0%) hydrogels under
differentiation conditions. (D) Encapsulated C2C12 cells after 5 days of
culture in 0.15% (w/v) NaGG hydrogels under differentiation conditions.
Cells were immunostained for the skeletal muscle protein desmin (red) and
nuclei stained with DAPI (blue). Scale bars represent 50 µm.

In contrast, assessing the differentiation of PC12 cells within
RGD-GG(1.0%) and NaGG hydrogels was problematic as cells
readily clustered in both materials. Neurite extension was
observed only for single cells or very small clusters (Figure S2,
ESI). Differentiation from larger cell clusters was impeded,
suggesting that the RGD density and/or GG concentration may
need to be further optimised for this cell type to achieve
improved cell differentiation. Our results for PC12 cells are in
agreement with previous studies on RGD-functionalised cell
culture plastic surfaces that showed that PC12 cells exhibited
enhancement in proliferation without significant morphological
changes46, 47. More recent work however has identified an
important role in local microstructure for controlling cell
behaviour48, and PC12 and C2C12 cells on RGD-modified
surfaces showed differing behaviour depending on the
microstructure employed 49, 50. In a similar manner, the local
density of RGD sites appears to play a significant role in
controlling the behaviour of attached cells41,42. In addition,
mechanical properties are known to impact cell behaviour 51,
and the fusion of C2C12 cells into myofibres has been shown to
be dependent on the mechanical properties of their
environment52.
In summary, we observed adhesion, spreading, proliferation
and differentiation into multinucleated fibres for C2C12 cells,
however PC12 cells showed enhancement only in overall
metabolic activity, broadly in line with previous findings41, 42, 46,
47
. Realising the potential of any material for tissue engineering
inevitably relies on tailoring its mechanical and biochemical
properties to match that of the target tissue. The tuneable
mechanical properties of GG 53, 54, and capacity for peptide
functionalisation, make it an excellent candidate for this role.

	
  

We have presented a covalent modification procedure for the
conjugation of short peptides to gellan gum. Purification of GG
was essential for successful conjugation, and optimisation of
coupling conditions resulted in a conjugation efficiency of
~40%. Rheological studies indicated that the attachment of
RGD to the carboxyl residues does not impede the formation of
hydrogels, although mechanical weaker gels are formed.
C2C12 and PC12 cell lines proliferated when seeded on the
surface and encapsulated into the gels and the increase in
overall cellular metabolic activity in RGD-GG hydrogels was
quantitated by MTS assay. The differentiation of the C2C12
cell line was enhanced by the RGD-peptide for both surface
seeded and encapsulated cells, resulting in multinucleated
skeletal muscle fibres either on the gel surface or throughout
the bulk of RGD-GG hydrogels.
This paper provides a reliable method for the
functionalisation of GG with short peptide sequences, with the
covalent linkage of G4RGDSY found to produce a significant
improvement to the cell attachment properties of GG. It is
anticipated that the reported enhancement in cell interactions
will increase the use of GG as a cell scaffolding biomaterial for
tissue engineering and a bio-ink for additive manufacturing
(3D-bioprinting).
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